|
|
|
EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Monday, 06 October 2014 09:00 - Wednesday, 08 October 2014 17:00
This year our pregnancy summit will discuss our current understanding of pre-eclampsia research and treatments. The last day will focus on the technologies currently available to assess pregnancy and pregnancy-associated conditions. This event has CPD accreditation. Who Should Attend Anyone working in the field of pregnancy and diagnosing pregnancy-related illnesses and pregnancy outcome will find this event beneficial. This includes Scientists,Obstetricians, Gynaecologists, Midwives, Clinical Chemists and Pharmaceutical and Medical devices professionals. This event has an open poster session. Posters can be submitted on any subject related to pregnancy The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at Program Outline
Day 1: Pre-eclampsia research
A maternal inflammatory response is characteristic for the maternal preeclampsia syndrome. During such a response inflammatory and angiogenic factors play crucial roles in the onset of and also sustaining the syndrome. The relation between these factors is subject for many studies world wide to improve the prognosis of preeclampsia and with a better prognosis the morbility and mortality of the syndrome should be improved. Session Chair: Mr Joost Schuitemaker,Managing Director, IQ Products, The Netherlands Day 2: Pre-eclampsia treatment and management Session Chair: To be confirmed
Day 3: Technologies to assess pregnancy and pregnancy-associated conditions. Session Chair: Professor Ray Iles, Chief Scientist, The ELK-Foundation for Health Research and MAP Diagnostics, UK Keywords: pregnancy, biomarkers, ectopic pregnancy, cost, microarray, proteomics, Pre-eclampsia; Fetal growth restriction; Placenta; Ultrasound, preterm delivery, intra-amniotic inflammation, histologic chorioamnionitis, cavity, Screening, Urinary metabolomics, mass sepctrometry,proteinuria , gestation, Folate NTD Epigenetics Genetics Pregnancy, MRI, circulation, oxygen, flow, placenta, Prenatal examinations, Chromosomal aberrations, Risk perception, Information, Informed choice, angiogenic factors, preeclampsia , adverse outcomes, risk startification, spinal anesthesia; epidural anesthesia; general anesthesia; perioperative management; cesarean section, labor; analgesia; opioids; neuraxial; preeclampsia, Preeclampsia, lymphocytes, cytokines, neutrophils, oxidative stress, depression, inflammation, cardiovascular disease, pre-eclampsia, cytokines, Pre-eclampsia, placenta, syncytiotrophoblast, microvesicles, exosomes , Cancer, pregnancy, HSIL, CIN, colposcopy, regnancy, central aortic blood pressure, augmentation index, arterial stiffness, pulse wave velocity, pre-eclampsia, prediction, long-term outcome, cardiovascular disease
|
|
|
|
|
|
Organized by:
|
|
Euroscicon |
|
Invited Speakers:
|
|
Talks Include: How can biomarkers be used to improve the management of pre-eclampsia? Professor Andrew Shennan, Kings College London, UK Preeclampsia Human Placental Model Professor Nandakumaran Moorkath, Faculty of Medicine, University of Kuwait
Stress, immune system functioning and perinatal depression: the impact of heightened systemic inflammation and risk of CVD later in life. Is pre-eclampsia the right model? Professor Meir Steiner, Professor Emeritus, McMaster University, Ontario, Canada
Placental Syncytiotrophoblast Vesicles In Normal Pregnancy And Pre-Eclampsia Dr Dionne Tannetta, Senior Research Scientist, University of Oxford, UK
Central aortic pulse wave analysis parameters - a novel marker in prediction of hypertensive complications in pregnancy Dr Ludwina Szczepaniak-Chicheł, MD, PhD, adiunct, Dept. of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, PolandPreeclampsia and the immune system: a close relationship Dr Estibalitz Laresgoiti, Associate Professor, Attending Physician, American British Cowdray Medical Center, Mexico, National Institute of Perinatology; Mexico, School of Medicine, Monterrey Institute of Technology and Higher Education, Mexico
Role of metabolic Syndrome factors in pre-eclampsia Dr Shipra Sonkusare, Dept. of Obstetrics + Gynaecology, Manipal University, India
Podocyturia as a diagnostic and prognostic marker of preeclampsia Dr Vesna D. Garovic, Professor of Internal Medicine, Division of Nephology+Hypertension+Dept of Obstetrics+Gynaecology, Mayo Clinic, USA
Vitamin D3 deficiency/treatment during pregnancy and complications including preeclampsia Dr Stella Nowicki, Professor Microbiology and Immunology, Meharry Medical College, Nashville, TN, USA
The hemostatic changes in preeclampsia, is there a place for anticoagulation treatment for the prevention of this syndrome? Professor Offer Erez, Director of Risk Management and Patients Safty Unit, Acting Director Maternal Fetal Medicine Unit, Soroka University Medical Center, Ben Gurion University of the Negev, Israel
Anesthetic Goals of Labor Analgesia in Preeclampsia Dr Ayten Saracoglu, Assist. Prof. M.D., Department of Anesthesiology and Reanimation, Istanbul Bilim University Medical School, Turkey
Pre-eclampsia casts a long shadow Professor Fiona Broughton Pipkin, Professor Emeritus of Perinatal Physiology, University of Nottingham Medical School, UK
Regional versus General Anesthesia for C/S in Severe Preeclampsia Dr Kemal Tolga Saracoglu, Assistant Professor of Anesthesiology and Reanimation, Marmara University School of Medicine Istanbul Turkey
Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment Dr Sarosh Rana, MD, Assistant Professor, Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA, USA
Pregnancy complicated by cervical cancer Dr Wojciech Kolawa, Senior lecturer, University Hospital, Department of Gynecology and Oncology, Jagiellonian University, Krakow, Poland
Fetal haemodyanic assessment by magnetic resonance imaging Dr Mike Seed, Pediatric Cardiologist and Radiologist, SickKids, Toronto, Canada
Was the Mona Lisa's Smile the Result of a Pregnancy-associated Condition? Dr William Maloney, DDS, Clinical Associate Professor, New York University, USA
Information about prenatal examinations - A challenge in antenatal care Associate Professor Susanne Georgsson Öhman, Senior Lecturer, Karolinska Institutet Department of women's and children's health, Stockholm, Sweden
The role of nutrition and genetics during pregnancy Dr Anne Parle-McDermott, Lecturer in Genetics, Dublin City University, Ireland
Catheter Ablation of Arrhythmia in Pregnant Women Dr John Ferguson, Associate Professor, University of Virginia Medical Center, USA
Additional Talks Include: Mr Joost Schuitemaker, Managing Director, IQ Products, The Netherlands Ms Ann Marie Barnard, Chief Executive Officer, Action on Pre-eclampsia Dr Heather A. Boyd, Department of Epidemiology Research, Statens Serum Institut, Denmark
|
|
|
|
|
|
Deadline for Abstracts:
|
|
July 10th 2014
|
|
|
|
|
|
Registration:
|
|
Click here to register
|
|
E-mail:
|
|
enquiries@euroscicon.com
|
|
|
|
|
|
|
|